Healthcare Leadership Council
Based in DC
🤖
AI Overview
With $1.5M in lobbying spend across 25 quarterly filings, Healthcare Leadership Council is a significant lobbying presence.
$1.5M
Total Lobbying Spend
25
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $180K |
| 2019 | $240K |
| 2020 | $240K |
| 2021 | $240K |
| 2022 | $180K |
| 2023 | $240K |
| 2024 | $160K |
Lobbying Firms
AVENUE SOLUTIONS
What They Lobby For
- Issues related to opioids policies; H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018); S. 2680, Opioid Crisis Response Act of 2018; Monitor drug pricing initiatives
- Stark Law modernization; S. 309, Community-Based Independence for Seniors Act H.R. 4006, Community-Based Independence for Seniors Act of 2017
- Issues related to opioids policies; H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018); S. 2680, Opioid Crisis Response Act of 2018; Monitor drug pricing initiatives; Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records
- Issues related to opioids policies; H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT for Patients and Communities Act); S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 (HEAL Act of 2018); S. 2680, Opioid Crisis Response Act of 2018; Monitor drug pricing initiatives; Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records; Issues related to value based payment arrangements; Health information technology & healthcare privacy issues; Issues related to privacy in the healthcare space
- Monitor healthcare cost initiatives; Issues related to 42 CFR Part 2 - Confidentiality of Substance Use Disorder Patient Records; Issues related to value based payment arrangements; Health information technology & healthcare privacy issues; Issues related to privacy in the healthcare space
- Stark Law modernization; Community-Based Independence for Seniors Act
- Issues related to privacy and data security legislation and its impact on HIPPA
- Stark Law modernization; Community-Based Independence for Seniors Act; Value of prescription drugs
- Monitor healthcare cost initiatives; Health information technology & healthcare privacy issues; Issues related to privacy in the healthcare space
- Monitor healthcare cost initiatives; Health information technology & healthcare privacy issues; Issues related to privacy in the healthcare space; H.R. 1865, Consolidated Domestic and International Assistance Bill
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.